CMIC CMO USA Announced New $7 Million Pharmaceutical Manufacturing Line in Cranbury
The new line represents a $7 million investment and expands CMIC’s capacity to support pharmaceutical products from development through commercial production.
Announced Aug. 27, the agreement includes an initial project with Singapore-based MuseCell Innovations Pte. Ltd. with the possibility for more ventures.
CMIC CMO USA Announced New $7 Million Pharmaceutical Manufacturing Line in Cranbury Read More »
Translate





